Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid
Conditions: Idiopathic Inflammatory Myopathies; Osteoporosis, Osteopenia Interventions: Drug: Denosumab; Drug: Zoledronic Acid Sponsors: Kwong Wah Hospital; Tung Wah Group of Hospitals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials